Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaGünter U. Höglinger, Christer Nilsson, Jennifer L. Whitwell et al.|Movement Disorders|2017Cited by 2.3k
Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodiesJosé Brás, John Hardy, Rita Guerreiro et al.|Human Molecular Genetics|2014Cited by 241
Trial of Deferiprone in Parkinson’s DiseaseDavid Devos, Christoph Scherfler, Julien Labreuche et al.|New England Journal of Medicine|2022Cited by 226
Which ante mortem clinical features predict progressive supranuclear palsy pathology?Gesine Respondek, Carolin Kurz, Thomas Arzberger et al.|Movement Disorders|2017Cited by 163
Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseasesRita Guerreiro, José Brás, Valentina Escott‐Price et al.|Neurobiology of Aging|2015Cited by 91